Lord's Mark Industries Limited has signed a landmark Technology Transfer Agreement (TTA) with the Centre for Materials for Electronic Technology (C-MET), an autonomous scientific society under India's Ministry of Electronics and Information Technology (MeitY). This collaboration aims to manufacture and commercialize the world's first AI-powered, radiation-free wearable device for early breast cancer detection.
The innovative device employs advanced thermal sensors combined with artificial intelligence-driven temperature mapping to identify early-stage abnormalities through non-invasive, painless screening that eliminates radiation exposure risks associated with traditional mammography. This partnership merges C-MET's R&D expertise with Lord's Mark's manufacturing and distribution strengths to deliver an affordable, portable solution for mass screening.
The global breast cancer diagnostics market is projected to reach approximately USD 12.88 billion by 2035, positioning the company at the forefront of India's indigenous Med-Tech sector. Lord's Mark plans to launch the product commercially across India and international markets by year-end.
Mr. Sachidanand Upadhyay, Managing Director (DIN: 01631728), emphasized the strategic significance: "This collaboration marks a defining step in our journey to build globally competitive, indigenous healthcare technologies."